SCHEMBL25394543

SCHEMBL25394543

CCCCC(CC)COC(=O)CC[S+]([O-])c1ccn2c(Cl)cnc2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ CA2 P00918 1/20 0.38
▸ LMNA P02545 3/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ RECQL P46063 1/20 0.34
▸ PRSS1 P07477 1/20 0.34
▸ PRSS2 P07478 1/20 0.34
▸ PRSS3 P35030 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25398148 0.81 CYP3A4 (0.44) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL23083642 0.66 CYP3A4 (0.46) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL44320 0.66 CYP3A4 (0.89) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL17916290 0.65 CYP3A4 (0.56) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL21811432 0.65 CYP3A4 (0.81) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL23833622 0.64 CYP3A4 (0.51) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL27423 0.64 CYP3A4 (1.00) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL1336595 0.64 CYP3A4 (0.86) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL247018 0.64 CYP3A4 (0.93) TSHRCYP3A4TDP1ATMALDH1A1
Ammonia Solution, Strong SCHEMBL16192512 0.64 CYP3A4 (0.86) TSHRCYP3A4TDP1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118369323-A Heterocyclic compounds as SHP2 inhibitors, compositions comprising the same, and methods of use thereof 捷思英达控股有限公司 2024-07-19 — — CN disclosed
WO-2023169170-A1 HETEROCYCLIC COMPOUND AS SHP2 INHIBITOR, COMPOSITION COMPRISING HETEROCYCLIC COMPOUND, AND METHOD USING SAME 捷思英达控股有限公司 2023-09-14 — — WO disclosed
Send feedback